Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07630389 · ClinicalTrials.gov registry record
Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
A clinical trial, sponsored by University of Rochester.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07630389 is a clinical trial that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants.
The verdict
NCT07630389 is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
Myotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study, we hope to learn more about these differences and what causes them. This is an observational study conducted in participants' homes and does not require travel. Instead, we will use video calls to talk with children and their parents/guardians about DM1 symptoms and how it affects the child's muscles, heart, and brain. We'll send families an iPad and the other tools they need for the study. During the video call, kids will do some simple activities to see how their body moves and functions. Parents/guardians might need to help their child with some of these activities. After the video visit, we'll get a small blood sample from the child. This can be done at a local lab or even at home. We'll then look at the child's genes in the blood sample to understand how they might be linked to their symptoms. Parents/guardians can chose to have their child's genetic test result returned to them.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-13 |
| Est. Completion | 2030-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07630389
The ClinicalTrials.gov registry entry for NCT07630389 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07630389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07630389 about?
NCT07630389 is a clinical study titled "Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy". Myotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study,...
What is the current status of trial NCT07630389?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-13. Estimated completion is 2030-01-01.
Who is sponsoring clinical trial NCT07630389?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.